Literature DB >> 14694134

Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virus.

Bruno Garulli1, Yoshihiro Kawaoka, Maria R Castrucci.   

Abstract

The humoral and cellular immune responses in the genital mucosa likely play an important role in the prevention of sexually transmitted infections, including infection with human immunodeficiency virus type 1 (HIV-1). Here we show that vaginal infection of progesterone-treated BALB/c mice with a recombinant influenza virus bearing the immunodominant P18IIIB cytotoxic T-lymphocyte (CTL) epitope of the gp160 envelope protein from an HIV-1 IIIB isolate (P18IIIB; RIQRGPGRAFVTIGK) can induce a specific immune response in regional mucosal lymph nodes, as well as in a systemic site (the spleen). A single inoculation of mice with the recombinant influenza virus induced long-lasting (at least 5 months) antigen-specific CTL memory detectable as a rapid recall of effector CTLs upon vaginal infection with recombinant vaccinia virus expressing HIV-1 IIIB envelope gene products. Long-term antigen-specific CTL memory was also induced and maintained in distant mucosal tissues when mice were intranasally immunized with the recombinant influenza virus. These results indicate that mucosal immunization and, in particular, local vaginal immunization with recombinant influenza virus can provide strong, durable immune responses in the female genital tract of mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14694134      PMCID: PMC368805          DOI: 10.1128/jvi.78.2.1020-1025.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes.

Authors:  M R Castrucci; S Hou; P C Doherty; Y Kawaoka
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

2.  Homing of mononuclear cells from iliac lymph nodes to the genital and rectal mucosa in non-human primates.

Authors:  E A Mitchell; L A Bergmeier; C Doyle; R Brookes; L A Hussain; Y Wang; T Lehner
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

Review 3.  Prime-boost immunization strategies against HIV.

Authors:  S W Barnett; J M Klinger; B Doe; C M Walker; L Hansen; A M Duliège; F M Sinangil
Journal:  AIDS Res Hum Retroviruses       Date:  1998-10       Impact factor: 2.205

4.  Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM.

Authors:  M Bomsel; M Heyman; H Hocini; S Lagaye; L Belec; C Dupont; C Desgranges
Journal:  Immunity       Date:  1998-08       Impact factor: 31.745

5.  Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts.

Authors:  L S Klavinskis; C Barnfield; L Gao; S Parker
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

6.  Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.

Authors:  N Bhardwaj; A Bender; N Gonzalez; L K Bui; M C Garrett; R M Steinman
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 7.  Mucosal immunity to infection with implications for vaccine development.

Authors:  H F Staats; R J Jackson; M Marinaro; I Takahashi; H Kiyono; J R McGhee
Journal:  Curr Opin Immunol       Date:  1994-08       Impact factor: 7.486

8.  Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.

Authors:  I M Belyakov; L S Wyatt; J D Ahlers; P Earl; C D Pendleton; B L Kelsall; W Strober; B Moss; J A Berzofsky
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

9.  A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.

Authors:  M B Parr; L Kepple; M R McDermott; M D Drew; J J Bozzola; E L Parr
Journal:  Lab Invest       Date:  1994-03       Impact factor: 5.662

10.  Maturation, activation, and protection of dendritic cells induced by double-stranded RNA.

Authors:  M Cella; M Salio; Y Sakakibara; H Langen; I Julkunen; A Lanzavecchia
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

View more
  7 in total

1.  Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.

Authors:  Zhu-Nan Li; Scott N Mueller; Ling Ye; Zhigao Bu; Chinglai Yang; Rafi Ahmed; David A Steinhauer
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Parallel human immunodeficiency virus type 1-specific CD8+ T-lymphocyte responses in blood and mucosa during chronic infection.

Authors:  F Javier Ibarrondo; Peter A Anton; Marie Fuerst; Hwee L Ng; Johnson T Wong; Jose Matud; Julie Elliott; Roger Shih; Mary Ann Hausner; Charles Price; Lance E Hultin; Patricia M Hultin; Beth D Jamieson; Otto O Yang
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Influenza viruses with rearranged genomes as live-attenuated vaccines.

Authors:  Lindomar Pena; Troy Sutton; Ashok Chockalingam; Sachin Kumar; Matthew Angel; Hongxia Shao; Hongjun Chen; Weizhong Li; Daniel R Perez
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

4.  Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus.

Authors:  Norifumi Iijima; Melissa M Linehan; Melodie Zamora; Debbie Butkus; Robert Dunn; Marilyn R Kehry; Terri M Laufer; Akiko Iwasaki
Journal:  J Exp Med       Date:  2008-12-01       Impact factor: 14.307

5.  Functional chimeras of human immunodeficiency virus type 1 Gp120 and influenza A virus (H3) hemagglutinin.

Authors:  K M Copeland; A J Elliot; R S Daniels
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 6.  Engineering influenza viral vectors.

Authors:  Junwei Li; Maria T Arévalo; Mingtao Zeng
Journal:  Bioengineered       Date:  2012-08-24       Impact factor: 3.269

7.  Induction of antibodies and T cell responses by a recombinant influenza virus carrying an HIV-1 TatΔ51-59 protein in mice.

Authors:  B Garulli; G Di Mario; M G Stillitano; D Compagnoni; F Titti; A Cafaro; B Ensoli; Y Kawaoka; M R Castrucci
Journal:  Biomed Res Int       Date:  2014-05-14       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.